Lincoln Pharmaceuticals consolidated net profit rises 2.25% in the September 2026 quarter

Sales rise 17.13% to Rs 191.35 crore

Net profit of Lincoln Pharmaceuticals rose 2.25% to Rs 20.43 crore in the quarter ended September 2026 as against Rs 19.98 crore during the previous quarter ended September 2025. Sales rose 17.13% to Rs 191.35 crore in the quarter ended September 2026 as against Rs 163.36 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	191.35	163.36	17
OPM %	12.38	15.57	-
PBDT	32.90	32.43	1
PBT	29.02	28.81	1
NP	20.43	19.98	2

Powered by Capital Market - Live News